tirzepatide: Hush Medical Spa Tirzepatide vs Semaglutide: 2026 Clinical

In people with diabetes, blood glucose levels may also rise once treatment is interrupted

Reduction in Cardiovascular Risk Factors: In addition to cardiovascular benefits, tirzepatide has been shown to reduce other risk factors associated with heart disease, such as blood pressure and lipid levels

Tirzepatide, a GLP-1 and GIP receptor agonist, has gained attention for its impressive effects in managing type 2 diabetes and facilitating weight loss

Some patients report that administering the injection in the evening reduces daytime nausea, while others prefer morning administration, though evidence for optimal timing is anecdotal

Common GLP-1-based medications include: Semaglutide (brand names: Wegovy, Ozempic) Tirzepatide (brand names: Zepbound, Mounjaro) Retatrutide (currently an investigational medication and not yet FDA-approved for weight loss) These medications work best when combined with a healthy diet, regular physical activity, and sustainable lifestyle changes